Segment Information by Division

January 1 to December 31

 (XLS:) Download XLS

 

  

 

€ million

  

Silicones

  

Polymers

  

Biosolutions

  

Polysilicon

  

Other

  

Consolidation

  

Group

1

Intangible assets; property, plant and equipment; investment property; excluding right-of-use assets

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 22.

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

2019

  

 

  

 

  

 

  

 

  

 

  

 

  

 

External sales

  

2,452.8

  

1,294.2

  

243.0

  

780.0

  

157.6

  

–

  

4,927.6

Internal sales

  

0.2

  

20.9

  

–

  

–

  

–

  

-21.1

  

–

Total sales

  

2,453.0

  

1,315.1

  

243.0

  

780.0

  

157.6

  

-21.1

  

4,927.6

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT

  

375.3

  

153.7

  

14.0

  

-1,012.9

  

-66.7

  

0.3

  

-536.3

Depreciation/amortization and impairment losses/reversals

  

103.2

  

40.5

  

17.1

  

1,069.8

  

89.1

  

–

  

1,319.7

EBITDA

  

478.5

  

194.2

  

31.1

  

56.9

  

22.4

  

0.3

  

783.4

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT includes:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

result from investments in joint ventures and associates

  

3.2

  

–

  

–

  

–

  

51.1

  

–

  

54.3

Impairment of fixed assets

  

-4.8

  

–

  

–

  

-760.0

  

–

  

–

  

-764.8

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Asset additions1

  

193.6

  

62.4

  

13.2

  

35.3

  

75.0

  

–

  

379.5

Additions to financial assets

  

–

  

–

  

–

  

–

  

6.6

  

–

  

6.6

Asset additions

  

193.6

  

62.4

  

13.2

  

35.3

  

81.6

  

–

  

386.1

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Assets (Dec. 31)

  

1,766.1

  

681.9

  

216.8

  

1,293.2

  

2,533.2

  

-0.2

  

6,491.0

Liabilities (Dec. 31)

  

929.2

  

331.4

  

97.4

  

584.9

  

2,519.1

  

–

  

4,462.0

Net assets (Dec. 31)

  

836.9

  

350.5

  

119.4

  

708.3

  

14.1

  

-0.2

  

2,029.0

Investments in joint ventures and associates included in net assets (Dec. 31)

  

42.7

  

–

  

–

  

–

  

597.7

  

–

  

640.4

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Research and development expenses

  

65.0

  

33.9

  

6.4

  

30.0

  

38.0

  

–

  

173.3

Employees (Dec. 31)

  

5,267

  

1,630

  

754

  

2,333

  

4,674

  

–

  

14,658

Employees (average)

  

5,293

  

1,623

  

737

  

2,441

  

4,657

  

–

  

14,751

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

2018

  

 

  

 

  

 

  

 

  

 

  

 

  

 

External sales

  

2,499.5

  

1,258.2

  

227.0

  

823.5

  

170.6

  

–

  

4,978.8

Internal sales

  

0.1

  

24.0

  

–

  

–

  

–

  

-24.1

  

–

Total sales

  

2,499.6

  

1,282.2

  

227.0

  

823.5

  

170.6

  

-24.1

  

4,978.8

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT

  

536.7

  

108.0

  

9.8

  

-257.3

  

-6.8

  

-0.8

  

389.6

Depreciation/amortization and impairment losses/reversals

  

79.9

  

39.7

  

13.7

  

329.7

  

77.4

  

–

  

540.4

EBITDA

  

616.6

  

147.7

  

23.5

  

72.4

  

70.6

  

-0.8

  

930.0

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT includes:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

result from investments in joint ventures and associates

  

31.8

  

–

  

–

  

–

  

99.9

  

–

  

131.7

Impairment of fixed assets

  

–

  

-1.4

  

–

  

–

  

–

  

–

  

-1.4

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Asset additions1

  

222.7

  

71.0

  

17.9

  

62.2

  

87.1

  

–

  

460.9

Additions to financial assets

  

–

  

–

  

–

  

–

  

–

  

–

  

–

Asset additions

  

222.7

  

71.0

  

17.9

  

62.2

  

87.1

  

–

  

460.9

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Assets (Dec. 31)

  

1,770.3

  

686.3

  

207.1

  

2,262.7

  

2,192.5

  

-0.2

  

7,118.7

Liabilities (Dec. 31)

  

826.3

  

307.6

  

78.2

  

712.4

  

2,048.9

  

-0.2

  

3,973.2

Net assets (Dec. 31)

  

944.0

  

378.7

  

128.9

  

1,550.3

  

143.6

  

–

  

3,145.5

Investments in joint ventures and associates included in net assets (Dec. 31)

  

41.7

  

–

  

–

  

–

  

616.6

  

–

  

658.3

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Research and development expenses

  

60.9

  

30.0

  

6.3

  

32.8

  

34.6

  

–

  

164.6

Employees (Dec. 31)

  

5,114

  

1,600

  

709

  

2,549

  

4,570

  

–

  

14,542

Employees (average)

  

4,990

  

1,575

  

665

  

2,548

  

4,523

  

–

  

14,301

todo Vorjahresvergleich